[go: up one dir, main page]

AU2002259301A1 - Caspase inhibitors and uses thereof - Google Patents

Caspase inhibitors and uses thereof

Info

Publication number
AU2002259301A1
AU2002259301A1 AU2002259301A AU2002259301A AU2002259301A1 AU 2002259301 A1 AU2002259301 A1 AU 2002259301A1 AU 2002259301 A AU2002259301 A AU 2002259301A AU 2002259301 A AU2002259301 A AU 2002259301A AU 2002259301 A1 AU2002259301 A1 AU 2002259301A1
Authority
AU
Australia
Prior art keywords
caspase inhibitors
caspase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002259301A
Inventor
Jean-Damien Charrier
Andrew Miller
Michael Mortimore
John Studley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of AU2002259301A1 publication Critical patent/AU2002259301A1/en
Abandoned legal-status Critical Current

Links

AU2002259301A 2001-05-23 2002-05-23 Caspase inhibitors and uses thereof Abandoned AU2002259301A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/292,969 2001-05-23

Publications (1)

Publication Number Publication Date
AU2002259301A1 true AU2002259301A1 (en) 2002-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
PL374598A1 (en) Caspase inhibitors and uses thereof
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002359694A1 (en) Compounds and methods
AU2001277519A1 (en) Bio-probes and use thereof
HK1063733A (en) Caspase inhibitors and uses thereof
AU2002259301A1 (en) Caspase inhibitors and uses thereof
AU2002359869A1 (en) Pak5-related compositions and methods
HK1051192A (en) Caspase inhibitors and uses thereof
WO2002099718A8 (en) Configuration systems and methods
HK1051182A (en) Caspase inhibitors and uses thereof
AU2002240498A1 (en) Protected deoxyadenosines and deoxyguanosines
AU2002228426A1 (en) Neurotonin and use thereof
AU2002332460A1 (en) Pyrazole-derived kinase inhibitors and uses thereof
AU2002305259A1 (en) Triazole-derived kinase inhibitors and uses thereof
AU2002228183A1 (en) Serpin variants and uses thereof